MORRIS GABRIEL S (Chief Financial Officer) purchased 0.9% of their position (2.60K shares) of IMMIX BIOPHARMA, INC. on the open market
Open‑market purchase worth $5.1K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 9/17/2025ACC: 0001493152-25-013918
DirectorOfficer· Chief Financial Officer
Since Dec 2021
+2.60K
Net shares
Net buyer
$5.1K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
2.60K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+2.60K
Price / share
$1.97
Trade value
$5.12K
% of position
0.9%
9/16/2025
288.06K→290.66K
Total
Net shares
+2.60K
Net value
$5.12K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/16/2025 | P · Purchase | +2.60K | $1.97 | $5.12K | 0.9% | 288.06K | 290.66K |
| Total | +2.60K | $5.12K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned24.14K
Common Stock
IndirectShares owned270.84K
Total
294.99K indirect294.99K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 24.14K | Indirect |
| Common Stock | 270.84K | Indirect |
| Total | 294.99K | 294.99K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported